165 related articles for article (PubMed ID: 35754147)
1. Aberrant TRPC1 expression reflects stromal cervical invasion, lymphovascular invasion, elevated FIGO stage, and poor survival in resectable endometrial carcinoma patients.
Wang Y; Zhang C
J Clin Lab Anal; 2022 Aug; 36(8):e24560. PubMed ID: 35754147
[TBL] [Abstract][Full Text] [Related]
2. Upregulated keratin 15 links to the occurrence of lymphovascular invasion, stromal cervical invasion as well as unfavorable survival profile in endometrial cancer patients.
Yang H; Li A; Li A; Zhao F; Zhang T
Medicine (Baltimore); 2022 Jul; 101(29):e29686. PubMed ID: 35866777
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated transient receptor potential channel 1 expression and its correlation with clinical features and survival profile in surgical non-small-cell lung cancer patients.
Ke C; Long S
J Clin Lab Anal; 2022 Mar; 36(3):e24229. PubMed ID: 35106847
[TBL] [Abstract][Full Text] [Related]
4. Is endometrial carcinoma intrinsically more aggressive in elderly patients?
Alektiar KM; Venkatraman E; Abu-Rustum N; Barakat RR
Cancer; 2003 Dec; 98(11):2368-77. PubMed ID: 14635071
[TBL] [Abstract][Full Text] [Related]
5. Tumor polo-like kinase 4 protein expression reflects lymphovascular invasion, higher Federation of Gynecology and Obstetrics stage, and shortened survival in endometrial cancer patients who undergo surgical resection.
Zhao Q; Wang M; Chen M
BMC Womens Health; 2024 Feb; 24(1):101. PubMed ID: 38326803
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.
Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V
Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis.
Shang P; Meng F; Liu Y; Chen X
Tumour Biol; 2015 Jun; 36(6):4479-85. PubMed ID: 25934333
[TBL] [Abstract][Full Text] [Related]
8. RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma.
Liu S; Lin M; Ji H; Ding J; Zhu J; Ma R; Meng F
Diagn Pathol; 2019 Jan; 14(1):7. PubMed ID: 30684972
[TBL] [Abstract][Full Text] [Related]
9. Rictor is an independent prognostic factor for endometrial carcinoma.
Wen SY; Li CH; Zhang YL; Bian YH; Ma L; Ge QL; Teng YC; Zhang ZG
Int J Clin Exp Pathol; 2014; 7(5):2068-78. PubMed ID: 24966915
[TBL] [Abstract][Full Text] [Related]
10. TRP channel expression correlates with the epithelial-mesenchymal transition and high-risk endometrial carcinoma.
Van den Eynde C; De Clercq K; Van Bree R; Luyten K; Annibali D; Amant F; Han S; Van Nieuwenhuysen E; Baert T; Peeraer K; Voets T; Van Gorp T; Vriens J
Cell Mol Life Sci; 2021 Dec; 79(1):26. PubMed ID: 34936030
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of myometrial invasion and TCGA groups of endometrial carcinoma.
Raffone A; Travaglino A; Raimondo D; Neola D; Renzulli F; Santoro A; Insabato L; Casadio P; Zannoni GF; Zullo F; Mollo A; Seracchioli R
Gynecol Oncol; 2021 Aug; 162(2):401-406. PubMed ID: 34088515
[TBL] [Abstract][Full Text] [Related]
12. [High expression of MMP20 may be a potential prognostic factor for poor outcomes of patients with endometrial carcinoma].
Zhao Q; Liu S
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1239-1244. PubMed ID: 30377136
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
[TBL] [Abstract][Full Text] [Related]
14. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
[TBL] [Abstract][Full Text] [Related]
15. CKMT1A is a novel potential prognostic biomarker in patients with endometrial cancer.
Wang Y; Zhao S; Qin Q; Gao X; Zhang X; Zhang M; Jiang Y; Ji X; Zhu H; Zhao X; Li H
PLoS One; 2022; 17(1):e0262000. PubMed ID: 35077462
[TBL] [Abstract][Full Text] [Related]
16. Vimentin Protein In Situ Expression Predicts Less Tumor Metastasis and Overall Better Survival of Endometrial Carcinoma.
Zhang X; Cao G; Diao X; Bai W; Zhang Y; Wang S
Dis Markers; 2022; 2022():5240046. PubMed ID: 35320951
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of HABP1 correlated with clinicopathological characteristics and unfavorable prognosis in endometrial cancer.
Zhao J; Liu T; Yu G; Wang J
Tumour Biol; 2015 Feb; 36(2):1299-306. PubMed ID: 25355598
[TBL] [Abstract][Full Text] [Related]
18. Transient Receptor Potential Channel 1 Potentially Serves as a Biomarker Indicating T/TNM Stages and Predicting Long-Term Prognosis in Patients With Renal Cell Carcinoma.
Chen L; Shan G; Ge M; Qian H; Xia Y
Front Surg; 2022; 9():853310. PubMed ID: 35548183
[TBL] [Abstract][Full Text] [Related]
19. Sirtuin2 correlates with lymph node metastasis, increased FIGO stage, worse overall survival, and reduced chemosensitivity to cisplatin and paclitaxel in endometrial cancer.
Tang Y; He Y; Zhao N; Chen Y; Xing J; Tang N
Ir J Med Sci; 2022 Feb; 191(1):147-154. PubMed ID: 33566315
[TBL] [Abstract][Full Text] [Related]
20. Expression of bone morphogenetic protein 10 in cases with endometrial carcinoma and its clinical significance.
Hu Y; Yu L; Xia F; Liang F; Cheng C; Huang Y; Xiao L
Clin Transl Oncol; 2021 Aug; 23(8):1711-1716. PubMed ID: 33635467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
